NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its first-quarter 2013 revenues increased 9 percent, driven by a 23 percent increase in royalty revenues year over year and a jump in assay sales.

Austin, Texas-based Luminex brought in total revenues of $53.2 million for the three months ended March 31, compared to revenues of $48.7 million for the first quarter of 2012. It beat the consensus Wall Street estimate for revenues of $52 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.